Financials
- Market Capitalization 47.85 B
- Employee 33 K
- Founded N/A
- CEO Richard Francis
- Website www.tevapharm.com
- Headquarter Israel
- FIGI BBG000C0CD58
- Industry Case Farmaceutiche - Specialistico e Generico
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
25.79
Rapporto prezzo/fatturato
2.1
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 359 | HLN Haleon plc American Depositary Shares | 9.31 USD | +0.65% | +5.32% | -0.85% | +2.99% | 41.67 B USD | ||
| 439 | ZTS Zoetis Inc. Class A Common Stock | 74.77 USD | +2.31% | +7.74% | +0.70% | -48.90% | 30.90 B USD | ||
| 450 | TAK Takeda Pharmaceutical Company Limited American Depositary Share | 18.73 USD | +1.24% | +5.22% | +0.92% | +32.04% | 29.18 B USD | ||
| 575 | VTRS Viatris Inc. - Common Stock | 17.64 USD | +1.15% | -1.01% | +5.82% | +70.43% | 20.26 B USD |